diabet
mellitu
metabol
disord
character
hyperglycemia
along
alter
carbohydr
lipid
protein
metabol
associ
complet
rel
defici
insulin
secret
andor
insulin
action
chronic
hyperglycemia
diabet
associ
long
term
damag
dysfunct
eventu
failur
organ
particularli
eye
kidney
nerv
cardiovascular
system
addit
hyperglycemia
sever
factor
dyslipidemia
hyperlipidemia
also
involv
develop
cardiovascular
complic
diabet
major
caus
morbid
mortal
world
health
organ
estim
million
peopl
worldwid
diabet
number
would
like
doubl
year
manag
diabet
insulin
synthet
oral
hypoglycem
drug
produc
seriou
side
effect
addit
fail
prevent
diabet
relat
complic
mani
patient
therefor
new
diabet
manag
strategi
obligatori
nowaday
effect
less
side
effect
synthet
drug
mani
speci
plant
plant
base
drug
describ
scientif
literatur
hypoglycem
activ
due
appar
effect
minim
side
effect
clinic
experi
rel
low
cost
theaflavin
major
chemic
constitu
black
tea
report
antioxid
anticanc
antiinflammatori
antimicrobi
antivir
abil
includ
bovin
coronaviru
bovin
rotaviru
influenza
etc
howev
antioxid
potenti
theaflavin
amelior
activ
key
enzym
glucos
metabol
high
fat
diet
streptozotocin
induc
diabet
rat
explor
far
therefor
present
studi
aim
evalu
effect
theaflavin
glucos
metabol
enzym
diabet
rat
structur
theaflavin
given
figur
theaflavin
streptozotocin
high
fat
diet
compon
cholesterol
bile
salt
egg
yolk
power
lard
obtain
sigma
chemic
compani
st
loui
mo
usa
sisco
research
laboratori
pvt
ltd
mumbai
india
central
drug
hous
pvt
ltd
new
delhi
india
skm
egg
product
export
india
limit
erod
tamil
nadu
india
lard
obtain
local
market
chennai
chemic
use
analyt
grade
male
albino
wistar
rat
weigh
g
bodi
weight
procur
central
anim
hous
facil
univers
madra
taramani
campu
chennai
tamil
nadu
india
maintain
ambient
temperatur
h
lightdark
cycl
anim
given
standard
commerci
rat
chow
water
ad
libitum
hous
standard
environment
condit
throughout
studi
experi
conduct
accord
ethic
norm
approv
ministri
social
justic
empower
govern
india
institut
anim
ethic
committe
guidelin
iaec
anim
divid
seven
group
six
anim
rat
fed
high
fat
diet
consist
ww
standard
laboratori
chow
lard
vv
yolk
powder
ww
cholesterol
ww
ww
bile
salt
week
week
anim
kept
overnight
fast
inject
low
dose
streptozotocin
mgkg
dissolv
sodium
citrat
buffer
ph
fast
blood
glucos
measur
three
day
inject
rat
fast
blood
glucos
level
mgdl
consid
diabet
diabet
rat
fed
highfat
diet
anoth
week
experi
total
rat
diabet
surviv
rat
normal
rat
divid
six
group
six
rat
day
treatment
anim
depriv
food
overnight
sacrif
decapit
blood
collect
two
differ
tube
ie
one
mixtur
potassium
oxal
sodium
fluorid
estim
plasma
insulin
glucos
anoth
ethylen
diamin
tetra
acet
acid
edta
estim
hemoglobin
glycat
hemoglobin
liver
kidney
tissu
excis
immedi
rins
icechil
normal
salin
remov
blood
known
weight
tissu
minc
homogen
ml
buffer
ph
ice
cold
condit
homogen
centrifug
supernat
use
estim
variou
biochem
paramet
section
pancrea
kept
asid
histolog
studi
bodi
weight
anim
record
prior
treatment
sacrific
food
water
intak
group
anim
monitor
daili
basi
day
fix
time
fix
amount
rat
chow
fluid
given
rat
replenish
next
day
plasma
glucos
estim
method
trinder
use
reagent
kit
trinder
haemoglobin
hb
glycat
haemoglobin
estim
method
drabkin
austin
sudhakar
pattabiraman
respect
plasma
insulin
measur
method
burgi
et
al
carbohydr
metabol
enzym
hexokinas
pyruv
kinas
lactat
dehydrogenas
dehydrogenas
glycogen
synthas
glycogen
phosphorylas
glycogen
content
estim
method
brandstrup
et
al
pogson
denton
king
koid
oda
gancedo
gancedo
ell
kirkman
leloir
goldemberg
cornblath
et
al
moral
et
al
respect
lipid
peroxid
hydroperoxid
estim
liver
kidney
tissu
method
niehiu
samuelsson
jiang
et
al
respect
catalas
cat
superoxid
dismutas
sod
glutathion
peroxidas
gpx
glutathionestransferas
gst
ascorb
acid
vitamin
c
tocopherol
vitamin
e
gsh
protein
determin
method
sinha
stringer
et
al
rotruck
et
al
habig
et
al
omay
et
al
baker
et
al
ellman
lowri
et
al
oral
glucos
toler
test
ogtt
perform
accord
method
du
vigneaud
karr
overnight
fast
minut
blood
sampl
ml
taken
control
experiment
rat
without
delay
glucos
solut
gkg
bodi
weight
administ
oral
gavag
blood
sampl
taken
min
glucos
administr
blood
sampl
collect
potassium
oxal
sodium
fluorid
glucos
level
determin
kit
method
trinder
pancreat
tissu
test
rat
fix
vv
formaldehyd
dri
evalu
arrang
ethanol
embed
paraffin
pancreat
section
thick
acquir
util
rotari
microtom
afterward
rehydr
section
stain
h
e
view
light
microscop
assess
presenc
cell
pancreat
tissu
variou
group
digit
imag
obtain
use
olympu
microscop
equip
camedia
digit
camera
olympu
america
inc
melvil
ny
usa
imag
taken
magnif
result
express
mean
sd
differ
group
assess
anova
use
student
softwar
packag
window
post
hoc
test
perform
intergroup
comparison
use
least
signific
differ
lsd
pvalu
consid
significantli
alter
blood
glucos
plasma
insulin
level
homeostat
model
assess
insulin
resist
normal
experiment
rat
given
tabl
diabet
rat
show
signific
increas
blood
glucos
signific
decreas
plasma
insulin
level
administr
theaflavin
mgkg
bw
differ
dose
diabet
rat
caus
signific
decreas
blood
glucos
level
signific
increas
plasma
insulin
compar
diabet
untreat
rat
context
diabet
rat
show
signific
increas
homair
compar
control
rat
supplement
differ
concentr
mgkg
bw
theaflavin
significantli
decreas
homair
index
dose
depend
manner
significantli
pronounc
effect
theaflavin
observ
dose
mgkg
bodi
weight
compar
two
dose
drug
effect
drug
compar
metformin
therefor
mgkg
bodi
weight
fix
effect
dose
use
analysi
result
ogtt
conduct
control
differ
experiment
group
shown
figur
oral
administr
glucos
normal
control
rat
blood
glucos
level
reach
fast
level
h
wherea
diabet
control
rat
blood
glucos
level
remain
peak
even
h
theaflavin
supplement
prevent
rise
blood
glucos
level
significantli
dose
depend
manner
howev
promin
glucos
lower
effect
found
dose
mgkg
bodi
weight
compar
two
dose
mgkg
b
w
min
result
almost
similar
diabet
rat
treat
metformin
compar
untreat
diabet
rat
signific
chang
observ
rat
administ
theaflavin
alon
compar
control
rat
chang
bodi
weight
food
water
intak
control
experiment
rat
depict
tabl
food
water
intak
elev
wherea
bodi
weight
significantli
decreas
diabet
rat
compar
normal
control
rat
daili
administr
theaflavin
metformin
diabet
rat
day
caus
signific
reduct
food
fluid
intak
increas
bodi
weight
compar
diabet
control
rat
level
hemoglobin
control
experiment
anim
depict
tabl
diabet
rat
show
signific
decreas
level
total
hemoglobin
signific
increas
level
compar
control
rat
level
total
hemoglobin
significantli
revers
administr
theaflavin
metformin
diabet
rat
normal
rat
treat
theaflavin
dose
mgkg
bodi
weight
show
signific
chang
plasma
glucos
insulin
hemoglobin
level
signific
decreas
muscl
liver
glycogen
content
well
glycogen
synthas
activ
concomit
increas
activ
glycogen
phosphorylas
observ
liver
diabet
rat
compar
normal
rat
oral
administr
theaflavin
metformin
diabet
rat
reinstat
glycogen
content
activ
glycogen
synthas
glycogen
phosphorylas
near
normal
level
respect
tissu
compar
untreat
diabet
rat
normal
rat
treat
theaflavin
show
signific
chang
glycogen
content
well
glycogen
synthas
glycogen
phosphorylas
tabl
effect
theaflavin
supplement
activ
hexokinas
pyruv
kinas
lactat
dehydrogenas
bisphosphatas
dehydrogenas
liver
kidney
tissu
control
experiment
rat
shown
tabl
signific
chang
level
paramet
control
rat
treat
theaflavin
alon
howev
activ
hexokinas
pyruv
kinas
dehydrogenas
significantli
decreas
wherea
activ
lactat
dehydrogenas
significantli
increas
liver
kidney
tissu
diabet
rat
treatment
theaflavin
metformin
diabet
rat
alter
activ
enzym
reinstat
near
normalci
liver
kidney
tissu
tabl
show
level
tbar
hydroperoxid
liver
kidney
tissu
control
experiment
rat
diabet
rat
show
increas
level
tbar
hydroperoxid
compar
normal
control
rat
oral
administr
theaflavin
diabet
rat
significantli
decreas
lipid
peroxid
marker
liver
kidney
tissu
tabl
illustr
activ
enzymat
antioxid
sod
cat
gpx
gst
gr
non
enzymat
antioxid
vitamin
c
vitamin
e
gsh
liver
kidney
control
experiment
rat
level
enzymat
non
enzymat
antioxid
significantli
decreas
diabet
rat
compar
control
rat
howev
theaflavin
administr
diabet
rat
significantli
improv
activ
enzym
figur
repres
hematoxylin
eosin
stain
pancrea
control
experiment
rat
normal
histolog
featur
exocrin
endocrin
part
shown
section
pancreat
tissu
control
rat
figur
pancreat
section
theaflavin
alon
treat
rat
show
chang
beta
cell
look
like
control
pancrea
figur
b
section
pancreat
tissu
diabet
rat
show
degen
chang
well
reduct
number
size
islet
subsequ
central
area
pancreat
islet
complet
empti
compar
control
rat
figur
c
section
pancreat
tissu
diabet
rat
treat
theaflavin
metformin
show
mark
regener
islet
signific
number
granul
cell
diabet
rat
moreov
sever
islet
well
granul
compar
pancreat
islet
diabet
rat
indic
improv
function
cell
reflect
increas
plasma
insulin
level
figur
e
mani
studi
report
highfat
diet
fed
rat
develop
insulin
resist
lowdos
streptozotocin
administr
known
induc
mild
impair
insulin
secret
mimic
natur
histori
type
diabet
sever
scientif
report
prove
drug
significantli
reduc
high
blood
sugar
regul
glycogen
synthesi
signific
maintain
normal
blood
sugar
improv
glucos
toler
henc
blood
glucos
key
marker
diagnosi
prognosi
diabet
mellitu
insulin
insuffici
caus
elev
level
blood
glucos
result
excess
product
endogen
glucos
hepat
well
extrahepat
tissu
gluconeogen
glycogenolyt
pathway
reduc
consumpt
glucos
glycolyt
tca
cycl
glycogen
hmp
pathway
variou
tissu
diabet
mellitu
present
studi
upon
treatment
theaflavin
metformin
significantli
lower
level
blood
glucos
improv
insulin
level
high
fat
diet
streptozotocin
induc
diabet
rat
glucos
lower
elev
insulin
level
brought
antioxid
potenti
theaflavin
consumpt
natur
phytochem
contain
antioxid
effect
report
potenti
health
benefit
help
regener
cell
protect
pancreat
islet
cytotox
effect
streptozotozin
diabet
character
loss
bodi
weight
might
result
augment
muscl
wast
tissu
loss
due
unavail
carbohydr
energi
sourc
present
studi
initi
final
bodi
weight
experiment
anim
measur
wherea
food
water
intak
evalu
daili
basi
though
food
water
intak
diabet
rat
increas
experiment
period
weight
gain
significantli
reduc
compar
control
anim
howev
theaflavin
metformin
administr
restor
said
paramet
near
normalci
find
clearli
show
theaflavin
normal
disturb
carbohydr
metabol
diabet
rat
exert
signific
antidiabet
effect
glycosyl
hemoglobin
clinic
marker
chronic
glycem
control
patient
diabet
mellitu
persist
hyperglycemia
lead
glycosyl
amino
group
lysin
residu
protein
condit
favor
reduct
level
total
hemoglobin
elev
glycosyl
hemoglobin
turn
directli
proport
blood
glucos
diabet
rat
show
higher
level
glycosyl
hemoglobin
indic
poor
glycem
control
treatment
theaflavin
metformin
diabet
rat
significantli
reduc
level
compar
untreat
diabet
rat
reflect
antioxid
potenti
theaflavin
metformin
longterm
control
hyperglycemia
insulin
secret
glycogen
primari
intracellular
storabl
form
glucos
level
variou
tissu
especi
liver
skelet
muscl
indic
direct
reflect
insulin
activ
sinc
insulin
regul
glycogen
storag
stimul
glycogen
synthas
inhibit
glycogen
phosphorylas
streptozotocin
caus
destruct
cell
islet
langerhan
result
mark
decreas
insulin
level
glycogen
content
liver
muscl
tissu
decreas
invas
glucos
liver
inhibit
absenc
insulin
result
show
supplement
theaflavin
metformin
diabet
rat
significantli
increas
glycogen
content
hepat
skelet
muscl
stimul
glycogen
synthas
inhibit
glycogen
phosphorylas
could
due
increas
insulin
level
liver
play
central
role
mainten
glucos
homeostasi
uncontrol
hepat
glycogenolysi
gluconeogenesi
decreas
util
glucos
insulin
depend
tissu
fundament
factor
contribut
condit
term
hyperglycemia
diabet
mellitu
hyperglycem
statu
occur
due
lack
suppress
hepat
glucos
product
absorpt
state
excess
glucos
product
post
absorpt
state
enzym
involv
regul
hepat
glucos
product
potenti
target
control
glucos
homeostasi
diabet
henc
current
studi
concentr
evalu
activ
hepat
key
enzym
carbohydr
metabol
streptozotocin
high
fat
diet
induc
diabet
rat
hexokinas
major
regulatori
enzym
involv
oxid
glucos
sinc
insulindepend
enzym
hepat
hexokinas
activ
diabet
rat
almost
entir
inhibit
inactiv
due
absenc
insulin
impair
result
mark
declin
rate
glucos
oxid
via
glycolysi
ultim
lead
hyperglycemia
markedli
decreas
level
insulin
observ
diabet
anim
ultim
lead
impair
activ
hexokinas
sinc
insulin
defici
clinic
imprint
diabet
upon
treatment
theaflavin
metformin
high
fat
diet
streptozotocin
induc
rat
result
notabl
revers
activ
hexokinas
diminish
fast
blood
glucos
level
observ
theaflavin
metformin
administ
diabet
rat
may
due
amplifi
hexokinas
activ
hepat
renal
tissu
therebi
increas
oxid
glucos
lead
control
glucos
homeostasi
pyruv
kinas
ubiquit
express
key
glycolyt
enzym
catalyz
convers
phosphoenolpyruv
pyruv
gener
atp
alter
express
could
expect
impair
glucos
metabol
energi
product
pyruv
kinas
regul
substrat
phosphoenolpyruv
intermedi
glycolysi
upregul
pyruv
kinas
observ
decreas
activ
pyruv
kinas
liver
kidney
streptozotocin
induc
diabet
rat
readili
account
decreas
util
glucos
glycolysi
increas
product
glucos
gluconeogenesi
liver
kidney
indic
two
pathway
alter
diabet
supplement
theaflavin
metformin
high
fat
diet
streptozotocin
induc
diabet
rat
result
signific
increas
activ
pyruv
kinas
improv
activ
hexokinas
pyruv
advoc
activ
util
glucos
lactat
dehydrogenas
termin
glycolyt
enzym
play
indispens
role
interconvers
pyruv
lactat
yield
energi
anaerob
condit
reaction
occur
cytosol
mitochondri
compart
studi
shown
diabet
activ
lactat
dehydrogenas
increas
due
impair
insulin
secret
result
agreement
studi
thu
increas
activ
ldh
interfer
normal
glucos
metabol
insulin
secret
cell
pancrea
may
therefor
directli
respons
insulin
secretori
defect
diabet
due
high
fat
diet
streptozotocin
induc
oxid
stress
mediat
cellular
damag
besid
elev
level
ldh
hepat
renal
tissu
indic
cell
damag
upon
treatment
theaflavin
metformin
diabet
rat
restor
ldh
activ
regul
nadpnadh
ratio
therebi
stimul
oxid
nadh
normal
ldh
activ
indic
improv
channel
pyruv
glucos
mitochondri
oxid
gluconeogen
enzym
involv
homeostat
regul
blood
glucos
concentr
mainli
liver
kidney
critic
provid
glucos
organ
diabet
prolong
fast
starvat
catalyz
dephosphoryl
glucos
catalyz
dephosphoryl
serv
site
regul
gluconeogenesi
increas
activ
liver
kidney
high
fat
diet
streptozotocin
induc
diabet
rat
may
due
insulin
inadequaci
theaflavin
metformin
supplement
diabet
rat
significantli
dwindl
activ
might
due
improv
insulin
secret
respons
repress
gluconeogen
key
enzym
activ
enzym
dehydrogenas
usual
found
decreas
diabet
condit
turn
slow
pentos
phosphat
pathway
consist
studi
administr
theaflavin
metformin
diabet
rat
significantli
increas
activ
dehydrogenas
provid
hydrogen
bind
nadp
produc
nadph
enhanc
synthesi
fat
carbohydr
ie
lipogenesi
final
plasma
glucos
level
decreas
present
studi
suggest
decreas
activ
dehydrogenas
clinic
signific
pathogenesi
diabet
complic
treatment
theaflavin
metformin
restor
activ
dehydrogenas
near
normalci
hyperglycemia
result
gener
free
radic
exhaust
antioxid
defens
thu
lead
disrupt
cellular
function
oxid
damag
membran
enhanc
suscept
lipid
peroxid
elev
lipid
peroxid
respons
format
lipid
hydroperoxid
level
tbar
hydroperoxid
found
higher
diabet
individu
compar
healthi
individu
studi
level
lipid
peroxid
hydroperoxid
significantli
increas
wherea
level
enzymat
antioxid
sod
cat
gpx
gst
gr
non
enzymat
antioxid
vitamin
c
vitamin
e
gsh
significantli
decreas
hepat
renal
tissu
diabet
rat
oral
administr
theaflavin
extract
significantli
improv
antioxid
statu
reduc
lipid
peroxid
hydroperoxid
liver
kidney
tissu
diabet
rat
antioxid
antiperoxid
properti
previou
studi
shown
oral
administr
black
tea
extract
increas
antioxid
enzym
pancrea
liver
kidney
cardiac
tissu
diabet
rat
moreov
leung
et
al
report
theaflavin
black
tea
possess
antioxid
activ
egcg
theaflavin
one
major
chemic
constitu
black
tea
prove
antioxid
properti
studi
result
present
studi
clearli
indic
oral
treatment
theaflavin
metformin
diabet
rat
increas
activ
hexokinas
pyruv
kinas
dehydrogenas
suggest
effect
util
glucos
enhanc
activ
glycogen
synthas
indic
improv
glycogen
content
liver
muscl
reduct
activ
gluconeogen
glycogenolyt
enzym
hepat
renal
tissu
diabet
rat
treat
drug
suggest
drug
amelior
alter
carbohydr
metabol
prevent
endogen
glucos
product
two
pathway
addit
theaflavin
protect
pancrea
peroxid
injuri
antioxid
properti
improv
histolog
chang
pancrea
also
support
paramet
investig
find
suggest
theaflavin
complet
potenc
develop
antihyperglycem
agent
treatment
diabet
mellitu
studi
progress
elicit
exact
mechan
behind
antihyperglycem
action
theaflavin
diabet
